y.eriksen
TL2 Moderator · Pune
Contributes reviews on supplier material. Based in Pune.
Joined 5 July 2025 · last posted 15h · groups: regional-na
90 posts, newest first. Showing up to 150.
-
Chain of custody for a sample you posted yourself — one year on Replied, post #33 · Sourcing › Independent verification · 27 Jul 2026 · 0 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Which categories are strict and which are relaxed, honestly Replied, post #34 · Start Here › Welcome · 21 Jul 2026 · 21 likes On post #30 — agreed on the reasoning, with one qualification. Trust levels accumulate over time and they give you access to small things like the ability to edit your…
-
What a regulator's shortage notice actually authorises Replied, post #9 · marked as the solution · Sourcing › Regulatory · 18 Jul 2026 · 7 likes post #8 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #80 · Analytics › Home & field testing · 13 Jul 2026 · 0 likes Coming back to post #78, because the follow-up matters more than the original answer. Precision of home tests: most consumer-accessible devices are not precise to the…
-
When a dose reduction is the correct response to a side effect Replied, post #38 · Practice › Dosing & titration · 12 Jul 2026 · 0 likes Picking up post #35: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #26 · Analytics › HPLC & UHPLC · 10 Jul 2026 · 27 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
Here for the analytics and not much else Replied, post #16 · Lounge › Introductions · 10 Jul 2026 · 9 likes Coming back to post #14, because the follow-up matters more than the original answer. No judgment: people come to this community from all backgrounds and with all…
-
Request: tag synonyms surfaced in search Replied, post #15 · Meta › Feature requests · 10 Jul 2026 · 29 likes On post #11 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
How much context is too much context in a first post? Replied, post #67 · Start Here › How to Ask · 10 Jul 2026 · 21 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #38 · Compounds › Secretagogues & GH axis · 6 Jul 2026 · 7 likes post #37 is right about the mechanism and I think understates the practical bit. Secretagogues and glucose tolerance: there is a mechanistic concern that sustained…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #9 · Evidence › Journal club · 30 Jun 2026 · 26 likes This follows post #6 rather than contradicting it. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #83 · Analytics › HPLC & UHPLC · 28 Jun 2026 · 1 like Worth separating two things that post #79 runs together. Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #28 · Research Methods › Statistics · 23 Jun 2026 · 0 likes I read post #26 twice before replying, because I had assumed the opposite. Absence of evidence and evidence of absence: if a study is small and finds no effect, that is…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #62 · Analytics › HPLC & UHPLC · 23 Jun 2026 · 26 likes post #61 answers the question as asked. The question underneath it is different. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #120 · Practice › Reconstitution · 20 Jun 2026 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Official shortage notices and what they authorise Replied, post #106 · Access › Shortages · 14 Jun 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Request: a per-category review queue Replied, post #36 · Meta › Feature requests · 14 Jun 2026 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Micronutrient adequacy at low total intake Replied, post #80 · Nutrition & Training › Protein & intake · 13 Jun 2026 · 19 likes On post #76 — agreed on the reasoning, with one qualification. Timing of protein: spreading protein intake across the day, with some at each meal, is more practical…
-
Injection volume, overload, and peak distortion Replied, post #45 · Analytics › HPLC & UHPLC · 10 Jun 2026 · 8 likes post #44 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
The anatomy of a question that gets answered within an hour Replied, post #73 · Start Here › How to Ask · 10 Jun 2026 · 12 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #16 · Compounds › Tirzepatide · 4 Jun 2026 · 0 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #40 · Clinical › Bloodwork · 4 Jun 2026 · 21 likes This follows post #37 rather than contradicting it. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #24 · Pharmacology › Pharmacokinetics · 1 Jun 2026 · 8 likes I read post #22 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
The best-written scientific paper you have read Replied, post #72 · Lounge › Off topic · 30 May 2026 · 25 likes Coming back to post #70, because the follow-up matters more than the original answer. Newer drugs and mechanisms: when a new drug launches or a new mechanism is…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #72 · Clinical › Bloodwork · 19 May 2026 · 22 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #27 · Practice › Administration · 14 May 2026 · 1 like post #26 answers the question as asked. The question underneath it is different. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #113 · Practice › Interactions · 5 May 2026 · 0 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #17 · Compounds › Tirzepatide · 3 May 2026 · 28 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #6 · Compounds › Tirzepatide · 28 Apr 2026 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #24 · Evidence › Study critique · 28 Apr 2026 · 1 like Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
Transporting a vial for a weekend away — a second dataset Replied, post #36 · Practice › Storage & stability · 24 Apr 2026 · 11 likes Coming back to post #34, because the follow-up matters more than the original answer. Container choice matters: the material of the vial, the rubber closure, the fill…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #45 · Practice › Administration · 5 Apr 2026 · 26 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Preprint servers and what screening they do Replied, post #95 · Evidence › Preprints · 19 Mar 2026 · 24 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
Which fields on a certificate actually matter, ranked Replied, post #11 · Analytics › COA interpretation · 13 Mar 2026 · 2 likes Coming back to post #9, because the follow-up matters more than the original answer. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #12 · Practice › Administration · 6 Mar 2026 · 7 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #33 · Research Methods › N-of-1 designs · 4 Mar 2026 · 0 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
-
Measurement error in a self-reported exposure Replied, post #79 · Evidence › Study critique · 25 Feb 2026 · 14 likes On post #75 — agreed on the reasoning, with one qualification. Bias towards the null and bias away from the null: different criticisms have different directions.…
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 25 Feb 2026 · 0 likes I read post #3 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #56 · Practice › Interactions · 22 Feb 2026 · 0 likes This follows post #53 rather than contradicting it. Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #7 · Practice › Administration · 19 Feb 2026 · 3 likes Picking up post #4: that is the part I would want checked first. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #47 · Outcomes › Progress reports · 13 Feb 2026 · 0 likes post #46 answers the question as asked. The question underneath it is different. Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is…
-
A history of disordered eating: proceeding carefully Replied, post #70 · Wellbeing › Mental health · 22 Jan 2026 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Amylin receptor signalling and satiety — what changed since Replied, post #19 · Pharmacology › Receptor biology · 21 Jan 2026 · 13 likes On post #15 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
A payment that went through twice: how it was resolved Replied, post #14 · Sourcing › Payments · 12 Jan 2026 · 4 likes Escrow services: some third-party services hold payment until the buyer confirms receipt. They add cost but reduce risk if the supplier is unknown.
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #8 · Regional › UK & Ireland · 12 Jan 2026 · 22 likes Worth separating two things that post #4 runs together. Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #6 · Evidence › Trials · 11 Jan 2026 · 23 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #56 · Access › Pricing · 7 Jan 2026 · 0 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #81 · Practice › Side effects · 29 Dec 2025 · 0 likes post #80 answers the question as asked. The question underneath it is different. Pancreatitis: a rare but serious event with a specific presentation (epigastric pain,…
-
How to ask about something you suspect is a bad idea Replied, post #34 · Start Here › How to Ask · 14 Dec 2025 · 21 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
When your prescriber and the evidence disagree Started this topic · Clinical › Prescriber conversations · 13 Dec 2025 · 48 likes When your prescriber and the evidence disagree — that is the question, and I have not found it answered plainly anywhere I have looked. General question, not a request…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #36 · Data & Tools › Calculators · 11 Dec 2025 · 9 likes Coming back to post #34, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #3 · Sourcing › Red flags · 29 Nov 2025 · 29 likes On the opening post — agreed on the reasoning, with one qualification. Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or…
-
Meeting a protein target on a suppressed appetite Replied, post #38 · Nutrition & Training › Protein & intake · 27 Nov 2025 · 2 likes On post #34 — agreed on the reasoning, with one qualification. Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain…
-
Reading U-100 graduations, with a conversion table Started this topic · Devices › Syringes & needles · 21 Nov 2025 · 3 likes Posting this under the heading it deserves: Reading U-100 graduations, with a conversion table Everything below is what sits behind that. Practical question with the…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #7 · Sourcing › Independent verification · 7 Nov 2025 · 10 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
What pooling buys you and what it destroys Replied, post #55 · Evidence › Meta-analyses · 31 Oct 2025 · 0 likes This follows post #52 rather than contradicting it. Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you…
-
Early satiety becoming a problem rather than a benefit Replied, post #4 · Practice › Side effects · 28 Oct 2025 · 0 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
-
Documentation that materially improves an appeal's chances Replied, post #39 · Access › Insurance & coverage · 25 Oct 2025 · 7 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
NHS criteria and how they are applied in practice — the long version Replied, post #6 · Regional › UK & Ireland · 19 Sep 2025 · 17 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #26 · Analytics › Method validation · 17 Sep 2025 · 2 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Trial registration and comparing the protocol with the paper Replied, post #38 · Evidence › Trials · 14 Sep 2025 · 0 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Insurance and replacement policies, compared — the long version Replied, post #14 · Sourcing › Logistics · 10 Sep 2025 · 0 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #89 · Data & Tools › Datasets · 9 Sep 2025 · 0 likes Combining data from different sources: datasets from this site are not directly comparable to published trials because the populations are different. They are worth…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #120 · Compounds › Tirzepatide · 7 Sep 2025 · 14 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #126 · Wellbeing › Mental health · 5 Sep 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #21 · Practice › Side effects · 28 Aug 2025 · 3 likes I read post #19 twice before replying, because I had assumed the opposite. Injection site reaction: local erythema, nodules, or induration at injection sites is…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #28 · Compounds › Other compounds · 26 Aug 2025 · 16 likes Coming back to post #26, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #31 · Data & Tools › Calculators · 21 Jun 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #9 · Documentation › Doc review · 5 Jun 2025 · 23 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice.
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #119 · Sourcing › Independent verification · 19 May 2025 · 16 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #84 · Compounds › Tirzepatide · 14 May 2025 · 0 likes This follows post #81 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Follow-up: Documentation that appears only after payment Replied, post #68 · Sourcing › Red flags · 11 May 2025 · 0 likes Worth separating two things that post #64 runs together. Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #56 · Compounds › Secretagogues & GH axis · 5 May 2025 · 31 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #14 · Nutrition & Training › Protein & intake · 2 May 2025 · 18 likes This follows post #11 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #103 · Analytics › COA interpretation · 20 Mar 2025 · 1 like On post #99 — agreed on the reasoning, with one qualification. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure…
-
Charge states for a 4 kDa peptide, worked through Replied, post #136 · Analytics › Mass spectrometry · 17 Mar 2025 · 0 likes I read post #134 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #104 · Sourcing › Regulatory · 13 Mar 2025 · 0 likes Picking up post #101: that is the part I would want checked first. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on…
-
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #13 · Access › Pricing · 11 Mar 2025 · 13 likes post #12 is right about the mechanism and I think understates the practical bit. Price variation between pharmacies: identical prescriptions can cost different amounts…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #22 · Wellbeing › Mental health · 26 Feb 2025 · 32 likes This follows post #19 rather than contradicting it. Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit…
-
When to suspect the method rather than the sample Replied, post #77 · Analytics › Method validation · 5 Feb 2025 · 15 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #104 · Compounds › Tirzepatide · 13 Jan 2025 · 5 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
The topic list is dense — is that deliberate? Replied, post #75 · Meta › Site feedback · 31 Dec 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #16 · Compounds › Tirzepatide · 26 Dec 2024 · 1 like SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Why "any advice?" is the least effective ending for a post Replied, post #114 · Start Here › How to Ask · 6 Dec 2024 · 6 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #48 · Evidence › Journal club · 2 Dec 2024 · 15 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
UK access routes, dated and sourced — a second dataset Replied, post #4 · Regional › UK & Ireland · 3 Nov 2024 · 13 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #51 · Analytics › Mass spectrometry · 20 Aug 2024 · 11 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #70 · Evidence › Journal club · 27 Jul 2024 · 0 likes Coming back to post #68, because the follow-up matters more than the original answer. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide…
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #3 · Safety › Contraindications · 12 Jul 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
The mass-error checker and its intended scope Replied, post #62 · Data & Tools › Calculators · 20 Jun 2024 · 0 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…